Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Libtayo ® (Cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted […]
Vinehealth and University of Surrey Awarded £1m Grant to Trial a Support App for Patients Undergoing Cancer Treatment
Vinehealth in partnership with University of Surrey have secured a grant from Innovate UK to undertake […]
Pink Luminous Breast (PLB) Takes Steps Toward FDA Class III Approval
Pink Luminous Breast (PLB) is continuing to make strides in breast cancer awareness with a new […]
MATWIN Highlights Four Innovative Projects in the Fight Against Cancer
MATWIN, the French oncology accelerator and subsidiary of Unicancer, today announces the four winners chosen […]
‘Never Done Before’ AI Study Could Improve Early Detection of Pancreatic Cancer
Artificial intelligence (AI) could potentially be used to aid early diagnosis of pancreatic cancer and […]
Viome Receives FDA Approval for its Unique mRNA Technology and AI Platform to Detect Cancers
Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its […]
UK Medicines Regulator Issues its First Authorisation Under Project Orbis
A post-surgery treatment for lung cancer will be the first to receive an authorisation from […]
Genes Responsible for High Blood Pressure Discovered in the Human Kidney
Research that the British Heart Foundation part-funded has led to the discovery of 179 kidney […]
Imfinzi, Tremelimumab and Chemotherapy Demonstrated Significant Benefit Versus Chemotherapy Alone
POSEIDON was a Phase III trial of AstraZeneca’s Imfinzi (durvalumab) plus platinum-based chemotherapy or Imfinzi, tremelimumab and chemotherapy […]
Roche’s Tecentriq Approved by European Commission
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more